These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338 [TBL] [Abstract][Full Text] [Related]
3. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of the presence of the mutation of the codons 12, 13 and 61 in K-ras oncogene in colorectal cancer]. Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P Orv Hetil; 1999 Jul; 140(30):1673-9. PubMed ID: 10461447 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer. Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P Anticancer Res; 2000; 20(3A):1695-701. PubMed ID: 10928094 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421 [TBL] [Abstract][Full Text] [Related]
8. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients. Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887 [TBL] [Abstract][Full Text] [Related]
9. A newly identified pattern of K-ras mutations at codons 12 and 13 is associated with long-term survival in colorectal cancer. Senagore AJ; Biener JT Surgery; 1997 Oct; 122(4):765-70. PubMed ID: 9347854 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of K-ras mutations in colorectal carcinoma. Benhattar J; Losi L; Chaubert P; Givel JC; Costa J Gastroenterology; 1993 Apr; 104(4):1044-8. PubMed ID: 8462792 [TBL] [Abstract][Full Text] [Related]
12. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer. Tortola S; Marcuello E; González I; Reyes G; Arribas R; Aiza G; Sancho FJ; Peinado MA; Capella G J Clin Oncol; 1999 May; 17(5):1375-81. PubMed ID: 10334521 [TBL] [Abstract][Full Text] [Related]
13. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Nollau P; Moser C; Weinland G; Wagener C Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253 [TBL] [Abstract][Full Text] [Related]
14. Predominance of G to A codon 12 mutation K-ras gene in Dukes' B colorectal cancer. Zulhabri O; Rahman J; Ismail S; Isa MR; Wan Zurinah WN Singapore Med J; 2012 Jan; 53(1):26-31. PubMed ID: 22252179 [TBL] [Abstract][Full Text] [Related]
15. Association of K-ras mutations with liver metastases from colorectal carcinoma. Tsunoda A; Iijima T; Tsunoda Y; Nakao K; Miyaki M; Kusano M Anticancer Res; 2004; 24(4):2471-6. PubMed ID: 15330200 [TBL] [Abstract][Full Text] [Related]
17. A relationship between K-ras gene mutations and some clinical and histologic variables in patients with primary colorectal carcinoma. Beránek M; Bures J; Palicka V; Jandík P; Langr F; Nejedlá E Clin Chem Lab Med; 1999 Jul; 37(7):723-7. PubMed ID: 10510729 [TBL] [Abstract][Full Text] [Related]
18. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K- Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239 [TBL] [Abstract][Full Text] [Related]
19. K-ras mutations in patients with early colorectal cancers. Andreyev HJ; Tilsed JV; Cunningham D; Sampson SA; Norman AR; Schneider HJ; Clarke PA Gut; 1997 Sep; 41(3):323-9. PubMed ID: 9378386 [TBL] [Abstract][Full Text] [Related]
20. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]